Coping with gastrointestinal and lung cancer without chemotherapy. Specialists at the Tel Aviv Sourasky Clinic (Ichilov) use an ultra-modern innovative method to combat neuroendocrine tumors. It is based on radionuclide therapy with the radioisotope Lutetium 177 (Lutetium-177). This innovation is a real breakthrough in oncotherapy, because in recent decades the number of cases of this type of cancer has been rapidly growing.
This method is completely new in the world. Today it exists only in Israel, Germany and Sweden.
Its essence is in the use of a new radiopharmaceutical - Lutetium 177 PRRT. The drug is administered intravenously at intervals of 7-8 weeks. With the help of Lutetium, cancer cells are destroyed selectively, without affecting healthy tissues of the body. That is, this method of treatment can literally be called "local radiation therapy". In addition, the drug does not have a toxic effect on the and kidneys, destroying the tumor from the inside.
In addition, the use of this method allows patients to avoid severe side effects of chemotherapy, such as vomiting, nausea, pain, alopecia, weakness. It is also important that the treatment is carried out by a special group of medical specialists. Among them: leading doctors, nurses and medical physicists!
All of them work under the supervision of Dr. Inna Ospovat, a leading specialist in the nuclear therapy department at the Ichilov Clinic.
Education
2000-1994 Faculty of Medicine in Vitebsk, Belarus.
Specialization
2003 - 2011 - specialization in oncology and radiation therapy at the Hadassah University Hospital in Jerusalem.
Recognized experience
Oncology and radiation therapy
Additional education
2015 - PMH University Hospital (Totonto) Childhood irradiation and head and neck tumors
Attending conferences
About 10 presentations at medical conferences
Trade union membership
Coping with gastrointestinal and lung cancer without chemotherapy. Specialists at the Tel Aviv Sourasky Clinic (Ichilov) use an ultra-modern innovative method to combat neuroendocrine tumors. It is based on radionuclide therapy with the radioisotope Lutetium 177 (Lutetium-177). This innovation is a real breakthrough in oncotherapy, because in recent decades the number of cases of this type of cancer has been rapidly growing.
This method is completely new in the world. Today it exists only in Israel, Germany and Sweden.
Its essence is in the use of a new radiopharmaceutical - Lutetium 177 PRRT. The drug is administered intravenously at intervals of 7-8 weeks. With the help of Lutetium, cancer cells are destroyed selectively, without affecting healthy tissues of the body. That is, this method of treatment can literally be called "local radiation therapy". In addition, the drug does not have a toxic effect on the and kidneys, destroying the tumor from the inside.
In addition, the use of this method allows patients to avoid severe side effects of chemotherapy, such as vomiting, nausea, pain, alopecia, weakness. It is also important that the treatment is carried out by a special group of medical specialists. Among them: leading doctors, nurses and medical physicists!
All of them work under the supervision of Dr. Inna Ospovat, a leading specialist in the nuclear therapy department at the Ichilov Clinic.
Education
2000-1994 Faculty of Medicine in Vitebsk, Belarus.
Specialization
2003 - 2011 - specialization in oncology and radiation therapy at the Hadassah University Hospital in Jerusalem.
Recognized experience
Oncology and radiation therapy
Additional education
2015 - PMH University Hospital (Totonto) Childhood irradiation and head and neck tumors
Attending conferences
About 10 presentations at medical conferences
Trade union membership
Oncologist
Read moreOncologist
| Doctor's visit | price on request |
| Lung segmentectomy | $15000 - $25000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | |
| Immunotherapy |
Professor Niu Lizhi is a renowned Chinese cancer doctor, President of Fuda Cancer Hospital, and expert in minimally invasive cryosurgery. He has performed over 10,000 cryosurgeries and 500 NanoKnife procedures, and is the author of over 100 papers in surgical oncology, cryosurgery, and NanoKnife. He is Vice-President of the Asian Society of Cryosurgery and the International Society of Cryosurgery, and a member of the Chinese Medication Association, the China Anti-Cancer Association, the International Hepato-Pancreato-Biliary Association, and the Chinese Society of Integrated Traditional Chinese and Western Medicine.
Read moreProfessor Niu Lizhi is a renowned Chinese cancer doctor, President of Fuda Cancer Hospital, and expert in minimally invasive cryosurgery. He has performed over 10,000 cryosurgeries and 500 NanoKnife procedures, and is the author of over 100 papers in surgical oncology, cryosurgery, and NanoKnife. He is Vice-President of the Asian Society of Cryosurgery and the International Society of Cryosurgery, and a member of the Chinese Medication Association, the China Anti-Cancer Association, the International Hepato-Pancreato-Biliary Association, and the Chinese Society of Integrated Traditional Chinese and Western Medicine.
Oncologist
Read moreOncologist
| Doctor's visit | price on request |
| Lung segmentectomy | $15000 - $25000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | |
| Immunotherapy |
| Doctor's visit | price on request |
| Brain tumor removal | $35000 - $80000 |
| Radiofrequency ablation | $7500 - $12500 |
| Transnasal resection of tumor | $35000 - $80000 |
| Doctor's visit | price on request |
| Brain tumor removal | $35000 - $80000 |
| Radiofrequency ablation | $7500 - $12500 |
| Transnasal resection of tumor | $35000 - $80000 |
Sholokh Vitaly Nikolaevich
29.11.1980
Specialty: surgeon, oncosurgeon
Areas of activity:
- all types of open surgical interventions on the abdominal organs
cavities.
- all types of laparoscopic (endoscopic) interventions on organs
abdominal cavity.
- minimally invasive phlebology (endovenous laser coagulation,
sclerotherapy, miniphlebectomy).
- routine and minimally invasive (laser) proctology.
Work experience: 16 years
1998 – 2004 – studies at the medical faculty of Odessa
State Medical University.
2004 – 2006 – internship in surgery.
2007 – 2018 – Resident of the Surgical Department No. 1 of Odessa
railway hospital.
2017 – 2018 – Assistant of the Department of Surgery No. 1 at the Odessa National
Medical University.
2018 – 2021 – Resident of the surgical department of LLC
"Cardica Assistance" (St. Catherine Clinic).
2021 – Resident of the surgical department of OMD clinic.
Since 2020 – consultant for a number of private medical centers.
Member of the Odessa Association of Surgeons
Member of the European Association of Endoscopic Surgeons (EAST)
Read moreSholokh Vitaly Nikolaevich
29.11.1980
Specialty: surgeon, oncosurgeon
Areas of activity:
- all types of open surgical interventions on the abdominal organs
cavities.
- all types of laparoscopic (endoscopic) interventions on organs
abdominal cavity.
- minimally invasive phlebology (endovenous laser coagulation,
sclerotherapy, miniphlebectomy).
- routine and minimally invasive (laser) proctology.
Work experience: 16 years
1998 – 2004 – studies at the medical faculty of Odessa
State Medical University.
2004 – 2006 – internship in surgery.
2007 – 2018 – Resident of the Surgical Department No. 1 of Odessa
railway hospital.
2017 – 2018 – Assistant of the Department of Surgery No. 1 at the Odessa National
Medical University.
2018 – 2021 – Resident of the surgical department of LLC
"Cardica Assistance" (St. Catherine Clinic).
2021 – Resident of the surgical department of OMD clinic.
Since 2020 – consultant for a number of private medical centers.
Member of the Odessa Association of Surgeons
Member of the European Association of Endoscopic Surgeons (EAST)
Dr. X has a Bachelor of Medicine from Ankara (1976), Specialization in Internal Medicine from Ankara (1981), and a Minor Specialization in Medical Oncology from Istanbul (1987). He has held various positions in Oncology and Internal Medicine since 1986, and is a Founding Member and active member of various oncology associations and scientific organizations such as the Turkish Oncology Association, Medical Oncology Association, Chemotherapy Association, European Society for Medical Oncology, American Society of Clinical Oncology, and European Association for Clinical Cancer Research.
Read moreDr. X has a Bachelor of Medicine from Ankara (1976), Specialization in Internal Medicine from Ankara (1981), and a Minor Specialization in Medical Oncology from Istanbul (1987). He has held various positions in Oncology and Internal Medicine since 1986, and is a Founding Member and active member of various oncology associations and scientific organizations such as the Turkish Oncology Association, Medical Oncology Association, Chemotherapy Association, European Society for Medical Oncology, American Society of Clinical Oncology, and European Association for Clinical Cancer Research.
| Doctor's visit | price on request |
| Radiotherapy for prostate cancer | $2000 - $4500 |
| Radiotherapy | $2000 - $4500 |
| Radiotherapy for lung cancer | $2000 - $4500 |
| Doctor's visit | price on request |
| Radiotherapy for prostate cancer | $2000 - $4500 |
| Radiotherapy | $2000 - $4500 |
| Radiotherapy for lung cancer | $2000 - $4500 |